IMU ASX Chart
Snapshot
Imugene Limited (IMU) is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. The Company's unique platform technologies seek to harness the body's immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | -36.09% |
| vs ASX 200 (1yr) | -84.14% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Sydney NSW 2000 |
| Website | www.imugene.com |
| Registry | Automic Group |
| Auditor | Grant Thornton Audit Pty Ltd |
| Date Listed | 2 Dec 1993 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 25/08/2026 | Report (Prelim) |
| 25/08/2026 | Report (Annual) |
| 24/02/2027 | Report (Interim) |
Former Company Names
- Vostech Limited (VOS), 26/08/2002
- Vos Industries Limited (VOS), 28/12/2000
- Vosfry Systems Australia Pty Ltd (VOS), 19/01/1990.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
IMU directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of IMU directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for IMU in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 31-10-25 | Precision BioSciences, Inc. | 19,491,635 | -- | 6.20 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 30-04-26 | Precision BioSciences, Inc. | 19,491,635 | 6.20 | -- |
| 24-07-25 | Paul Hopper | 422,219,760 | 5.77 | -- |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.013 | 30 June |
| 2024 | $0.057 | 28 June |
| 2023 | $0.091 | 30 June |
| 2022 | $0.18 | 30 June |
| 2021 | $0.355 | 30 June |
| 2020 | $0.031 | 30 June |
| 2019 | $0.016 | 28 June |
| 2018 | $0.029 | 29 June |
| 2017 | $0.014 | 30 June |
| 2016 | $0.008 | 30 June |
| 2015 | $0.011 | 30 June |
| 2014 | $0.013 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.